Search

everythinglearnresearchcommunity

for

Search:↓

Injectable platelet-rich fibrin (I-PRF) is more effective than platelet-rich plasma (PRP) for treating hair loss.

RXRα is crucial for proper immune response and links diet to immune function.

Nelfb is crucial for forming skin fat tissue by regulating genes needed for fat cell development.

Gene variation affects prostate issues and hair loss.

A rare genetic mutation found in an Indian family can be detected through prenatal screening.

Double-spin PRP is more effective for treating female hair loss than single-spin PRP.

A new genetic mutation linked to CARASIL syndrome and small artery disease was found in a Chinese family.

Using platelet-rich fibrin matrix with hair transplant techniques helps in hair regrowth in male baldness patients.

Platelet-rich plasma helps human hair cells grow and survive better.

CAP1/Prss8 does not activate PAR2 or inhibit PN-1.

EGFR and MEK inhibitors reduce PD-L1 in hair follicles, possibly causing inflammation.

PADI4 enzyme slows down cell growth in developing hair follicles.

PRP treatments for hair loss need standard protocols to be reliable.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

CD8+ T cells re-expressing CD45RA may predict treatment resistance in severe alopecia areata.

Platelet-Rich Plasma (PRP) increases the number of new hair follicles and speeds up hair formation.

CRABP1 boosts hair cell growth in Hu sheep by affecting key genes.

Different types of PPARγ are found in varying amounts in human skin and its parts, which could affect how skin treatments work.

The protein AtRXR3 limits root hair growth in Arabidopsis, affecting phosphorus uptake.

MicroRNA-302 helps improve the conversion of body cells into stem cells by blocking NR2F2.

Angio PRP speeds up skin wound healing and reduces inflammation.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

PRP's effectiveness in healing is unclear and needs more research.

PBX1 reduces aging and cell death in stem cells by boosting SIRT1 and lowering PARP1.

PRP treatment satisfies 58% of female hair loss patients, with most noticing fuller, thicker hair and less shedding.

PRP may help with female hair loss short-term, but more research is needed for best results.

PTHrP is important for bone formation and may be targeted for osteoporosis treatment and longevity therapies.

Gorab deficiency speeds up skin aging by disrupting protein regulation and reducing collagen.

The enzyme PA-PLA1α is important for proper hair follicle development.